143 related articles for article (PubMed ID: 11431415)
21. Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells.
Schümann J; Voyle RB; Wei BY; MacDonald HR
J Immunol; 2003 Jun; 170(12):5815-9. PubMed ID: 12794105
[TBL] [Abstract][Full Text] [Related]
22. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.
Kawano T; Cui J; Koezuka Y; Toura I; Kaneko Y; Motoki K; Ueno H; Nakagawa R; Sato H; Kondo E; Koseki H; Taniguchi M
Science; 1997 Nov; 278(5343):1626-9. PubMed ID: 9374463
[TBL] [Abstract][Full Text] [Related]
23. Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells.
Schümann J; Pittoni P; Tonti E; Macdonald HR; Dellabona P; Casorati G
J Immunol; 2005 Dec; 175(11):7303-10. PubMed ID: 16301636
[TBL] [Abstract][Full Text] [Related]
24. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.
Benlagha K; Weiss A; Beavis A; Teyton L; Bendelac A
J Exp Med; 2000 Jun; 191(11):1895-903. PubMed ID: 10839805
[TBL] [Abstract][Full Text] [Related]
25. NKT TCR recognition of CD1d-α-C-galactosylceramide.
Patel O; Cameron G; Pellicci DG; Liu Z; Byun HS; Beddoe T; McCluskey J; Franck RW; Castaño AR; Harrak Y; Llebaria A; Bittman R; Porcelli SA; Godfrey DI; Rossjohn J
J Immunol; 2011 Nov; 187(9):4705-13. PubMed ID: 21964029
[TBL] [Abstract][Full Text] [Related]
26. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex.
Wun KS; Ross F; Patel O; Besra GS; Porcelli SA; Richardson SK; Keshipeddy S; Howell AR; Godfrey DI; Rossjohn J
J Biol Chem; 2012 Nov; 287(46):39139-48. PubMed ID: 22995911
[TBL] [Abstract][Full Text] [Related]
27. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells.
Sriram V; Du W; Gervay-Hague J; Brutkiewicz RR
Eur J Immunol; 2005 Jun; 35(6):1692-701. PubMed ID: 15915536
[TBL] [Abstract][Full Text] [Related]
28. The mouse CD1d cytoplasmic tail mediates CD1d trafficking and antigen presentation by adaptor protein 3-dependent and -independent mechanisms.
Lawton AP; Prigozy TI; Brossay L; Pei B; Khurana A; Martin D; Zhu T; Späte K; Ozga M; Höning S; Bakke O; Kronenberg M
J Immunol; 2005 Mar; 174(6):3179-86. PubMed ID: 15749847
[TBL] [Abstract][Full Text] [Related]
29. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.
Osman Y; Kawamura T; Naito T; Takeda K; Van Kaer L; Okumura K; Abo T
Eur J Immunol; 2000 Jul; 30(7):1919-28. PubMed ID: 10940881
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
[TBL] [Abstract][Full Text] [Related]
31. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.
Singh AK; Wilson MT; Hong S; Olivares-Villagómez D; Du C; Stanic AK; Joyce S; Sriram S; Koezuka Y; Van Kaer L
J Exp Med; 2001 Dec; 194(12):1801-11. PubMed ID: 11748281
[TBL] [Abstract][Full Text] [Related]
32. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
[TBL] [Abstract][Full Text] [Related]
33. The crystal structure of human CD1d with and without alpha-galactosylceramide.
Koch M; Stronge VS; Shepherd D; Gadola SD; Mathew B; Ritter G; Fersht AR; Besra GS; Schmidt RR; Jones EY; Cerundolo V
Nat Immunol; 2005 Aug; 6(8):819-26. PubMed ID: 16007090
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation.
Giabbai B; Sidobre S; Crispin MD; Sanchez-Ruìz Y; Bachi A; Kronenberg M; Wilson IA; Degano M
J Immunol; 2005 Jul; 175(2):977-84. PubMed ID: 16002697
[TBL] [Abstract][Full Text] [Related]
35. Murine CD1d-restricted T cell recognition of cellular lipids.
Gumperz JE; Roy C; Makowska A; Lum D; Sugita M; Podrebarac T; Koezuka Y; Porcelli SA; Cardell S; Brenner MB; Behar SM
Immunity; 2000 Feb; 12(2):211-21. PubMed ID: 10714687
[TBL] [Abstract][Full Text] [Related]
36. The biology of NKT cells.
Bendelac A; Savage PB; Teyton L
Annu Rev Immunol; 2007; 25():297-336. PubMed ID: 17150027
[TBL] [Abstract][Full Text] [Related]
37. Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production.
Liang PH; Imamura M; Li X; Wu D; Fujio M; Guy RT; Wu BC; Tsuji M; Wong CH
J Am Chem Soc; 2008 Sep; 130(37):12348-54. PubMed ID: 18712867
[TBL] [Abstract][Full Text] [Related]
38. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors.
Brigl M; van den Elzen P; Chen X; Meyers JH; Wu D; Wong CH; Reddington F; Illarianov PA; Besra GS; Brenner MB; Gumperz JE
J Immunol; 2006 Mar; 176(6):3625-34. PubMed ID: 16517731
[TBL] [Abstract][Full Text] [Related]
39. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
40. Glycolipid antigen processing for presentation by CD1d molecules.
Prigozy TI; Naidenko O; Qasba P; Elewaut D; Brossay L; Khurana A; Natori T; Koezuka Y; Kulkarni A; Kronenberg M
Science; 2001 Jan; 291(5504):664-7. PubMed ID: 11158680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
